Adaptive Phage Therapeutics Email Format

Biotechnology ResearchMaryland, United States2-10 Employees

Adaptive Phage Therapeutics is a clinical-stage biotechnology company based in Gaithersburg, Maryland, focused on therapies for multidrug-resistant infections. It maintains a growing library of phages and uses a proprietary matching assay to tailor treatment to individual patients, providing broad coverage against diverse pathogens. The firm partners with Mayo Clinic Laboratories to support global use of its matching approach.

The underlying technology originated in the biodefense program of the U.S. Department of Defense, from which APT secured worldwide exclusive commercial rights in 2017. Under an FDA emergency Investigational New Drug allowance, the company has provided investigational PhageBank therapy to more than 40 critically ill patients where standard-of-care antibiotics had failed. The company operates in the biotechnology research sector and targets physicians and healthcare providers seeking alternatives for hard-to-treat infections.

Get verified Adaptive Phage Therapeutics emails free

Company overview Employee directory